Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
High-dose Prednisone in Duchenne Muscular Dystrophy
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sudden Deafness Treatment Trial
- Status
- COMPLETED
- Phase
- PHASE3
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3